Breast cancer, Secondary cancers
Results
Phase 2
This trial looked at different treatment options for women with certain . It was for women who had breast cancer that had:
come back (recurrent or locally advanced breast cancer) or
spread to another part of the body (secondary or metastatic breast cancer)
The trial was supported by Cancer Research UK. It was open for people to join between 2016 and 2020. The team published results in 2020 and 2023.
Recruitment start: 21 December 2016
Recruitment end: 27 August 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nicholas Turner
Cancer Research UK
ICR Clinical Trials and Statistics Unit
Stand Up To Cancer
The Institute of Cancer Research
The Royal Marsden NHS Foundation Trust
AstraZeneca
Puma Biotechnology
There is more information about this trial on the plasmaMATCH website.
Last reviewed: 8 February 2024
CRUK internal database number: 13382